DRD3 anticorps (Cytoplasmic Domain)

N° du produit ABIN5576834

Détail du produit anti-DRD3 anticorps

Antigène: DRD3 (Dopamine Receptor D3 (DRD3))

Épitope: Cytoplasmic Domain

Reactivité: Humain, Souris, Chien, Cheval, Porc, Singe, Hamster, Chimpanzé

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp DRD3 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of DRD3.

Specificité: BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Réactivité croisée: Chimpanzé, Chien, Hamster, Cheval, Humain, Singe, Souris, Porc

Réactivité croisée (Details): BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Immunogène: A synthetic peptide corresponding to 18 amino acid at cytoplasmic domain of human DRD3.

Information d'application

Indications d'application: Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (16-32 μg/mL)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-80 °C

Stockage commentaire: Store at 4°C. For long term storage store at -80°C.
Aliquot to avoid repeated freezing and thawing.

Détails sur DRD3

Antigène: DRD3 (Dopamine Receptor D3 (DRD3))

Autre désignation: DRD3 (DRD3 Produits)

Synonymes: anticorps DRD3, anticorps D3R, anticorps D3DR, anticorps ETM1, anticorps FET1, anticorps dopamine receptor D3, anticorps drd3, anticorps DRD3, anticorps Drd3

Sujet: Full Gene Name: dopamine receptor D3
Synonyms: D3DR,ETM1,FET1,MGC149204,MGC149205

ID gène: 1814

Pathways: Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Proton Transport, Negative Regulation of Transporter Activity